CSIMarket Company Name, Ticker, Competitors, else..
 
Cel sci Corporation  (NYSE: CVM)
Other Ticker:  
 
 

CVM's Market share relative to its competitors, as of Q1 2025

As of Q1 2025 (Revenue in Millions of $)

Date modified: 2025-05-15T03:53:09+00:00




 
COMPANY NAME REVENUES
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months
Q1 2025		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE
A Quarter Before
Q4 2024
Cel sci Corporation 0.00 0.00% 0.00 % 0.00 %
Amgen Inc 33,424.00 46.59% 50.00% 45.77%
Gilead Sciences Inc 28,735.00 40.06% 36.69% 40.74%
Incyte Corporation 4,413.23 6.15% 5.79% 6.34%
Seagen Inc 2,300.35 3.21% 3.57% 3.25%
Exelixis Inc 2,298.92 3.20% 3.06% 3.05%
Immunogen inc 287.61 0.40% 0.62% 0.45%
Iovance Biotherapeutics inc 212.68 0.30% 0.27% 0.40%
Ikena Oncology Inc 30.38 0.04% 0.00% 0.00%
Revolution Medicines Inc 29.51 0.04% 0.00% 0.00%
Cardiff Oncology Inc 2.67 0.00% 0.00% 0.00%
SUBTOTAL 71,734.35 100% 18,172.85 100%



CVM's Market share relative to its competitors, as of Q1 2025 within the Biotechnology & Pharmaceuticals Industry
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Cel sci Corporation 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 49.86% 49.41% 53.43% 49.10%
Gilead Sciences Inc 42.87% 43.67% 39.20% 43.71%
Seagen Inc 3.43% 3.28% 3.81% 3.49%
Exelixis Inc 3.43% 3.29% 3.27% 3.27%
Iovance Biotherapeutics inc 0.32% 0.25% 0.29% 0.43%
Ikena Oncology Inc 0.05% 0.04% 0.00% 0.00%
Revolution Medicines Inc 0.04% 0.04% 0.00% 0.00%
Cardiff Oncology Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



CVM's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Cel sci Corporation 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 46.59% 46.30% 50.00% 45.77%
Gilead Sciences Inc 40.06% 40.92% 36.69% 40.74%
Incyte Corporation 6.15% 6.04% 5.79% 6.34%
Seagen Inc 3.21% 3.08% 3.57% 3.25%
Exelixis Inc 3.20% 3.09% 3.06% 3.05%
Immunogen inc 0.40% 0.27% 0.62% 0.45%
Iovance Biotherapeutics inc 0.30% 0.23% 0.27% 0.40%
Ikena Oncology Inc 0.04% 0.04% 0.00% 0.00%
Revolution Medicines Inc 0.04% 0.04% 0.00% 0.00%
Cardiff Oncology Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Cel sci Corporation's market divisions, geographic dispersion, segments, products, and services, visit Cel sci Corporation's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com